Cambridge researchers named as 2025 Academy of Medical Sciences Fellows
22 May 2025Four Cambridge biomedical and health researchers are among those announced today as newly-elected Fellows of the Academy of Medical Sciences.
Four Cambridge biomedical and health researchers are among those announced today as newly-elected Fellows of the Academy of Medical Sciences.
A new treatment approach significantly improves survival rates for patients with aggressive, inherited breast cancers, according to Cambridge researchers.
How AI supercomputer, Dawn, is being used to tackle some of the most pressing issues facing humanity.
Dr Mireia Crispin is an Assistant Professor in the Department of Oncology at the University of Cambridge and leads a research group focusing on the development of multi-omic data integration models to understand how tumours evolve and respond to treatment.
Meet the winner of the Cambridge Awards 2024 for Research Impact and Engagement and learn more about their projects.
The creation of the new Clinical Professorship signals the importance of AI in the fight against cancer and builds on the University’s work to apply the latest technology to the world’s major challenges.
Ten outstanding Cambridge researchers have been elected as Fellows of the Royal Society, the UK’s national academy of sciences and the oldest science academy in continuous existence.
Many people with breast cancer ‘systematically left behind’, say researchers in Lancet Commission led by Professor Charlotte Coles.
Treatment times for radiotherapy could be reduced for some early breast cancer patients, according to a trial led by University of Cambridge and The Institute of Cancer Research, London.
Seven Cambridge University researchers are among the 59 biomedical and health researchers elected to the Academy of Medical Sciences Fellowship.